Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)

$2.35M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Sloan-Kettering Inst Can Research
Country	United States
Start Date	Sep 01, 2023
End Date	Aug 31, 2028
Duration	1,826 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10918340`

Grant Description

PROJECT SUMMARY / ABSTRACT Cancer is the second most frequent cause of death in children under 15-years of age, and primary central nervous system (CNS) tumors are the most frequent cause of cancer-related childhood deaths. Medulloblastoma (MB) is the most frequent malignant childhood brain tumor (incidence of 5.5/million/year). About 40% of cases

occur in children